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Acute respiratory disease is, beside prematu-
rity, the leading cause for hospitalisation in neona-
tal intensive care units [1]. Respiratory distress
syndrome (RDS) is defined as the presence of at
least two of the following clinical signs: tachypnoea
(>60/min), dyspnoea with inspiratory subcostal or
intercostal retractions, nasal flaring, expiratory
grunting and cyanosis in room air. The most fre-
Objective: Severe respiratory distress syndrome
(RDS) caused by surfactant deficiency is described
not only in preterm infants but also in (near-) term
babies after caesarean section (CS), especially
when carried out before the onset of labour. The
aim of the present study was to document the
severity of this theoretically avoidable entity in
order to improve obstetric and perinatal care.
Patients: All neonates admitted to the paedi-
atric intensive care unit of the University Hospital
of Bern between 1988 and 2000 with RDS on the
basis of hyaline membrane disease (HMD) need-
ing mechanical ventilation (MV) after CS and with
a birthweight ≥2500 g were analysed. HMD was
diagnosed when respiratory distress and the typi-
cal radiological signs were present. Patients were
grouped into elective CS before onset of labour
and before rupture of membranes (group 1, n = 34)
and patients delivered by emergency CS or CS
after onset of labour or rupture of membranes
(group 2, n = 22). Analysed indices for severity of
illness were duration of stay in intensive care unit
and MV, ventilation mode, worst oxygenation
index (OI), presence of pulmonary air leak, and
systemic hypotension.
Results: Mean gestational age (GA) was 37 2/7
weeks in group 1 and 36 2/7 weeks in group 2; no
patient had a GA of ≥39 0/7 weeks. Duration of
MV was 4.4 days in group 1 and 3.9 days in group
2. Thirteen patients (38%) of group 1 and 7 (32%)
of group 2 had to be managed by rescue high-fre-
quency ventilation. A total of 7 patients had an OI
>40. Eight patients (24%) in group 1 and 4 (18%)
in group 2 developed a pulmonary air leak. Four-
teen neonates (41%) in group 1 had to be sup-
ported by catecholamines versus 5 (22%) in group
2. There was one death in group 1. 
Conclusion: Severe RDS on the basis of HMD
can also occur in near-term babies after CS; even
a fatal outcome can not be excluded. The severity
of illness in elective CS without labour may be
quite high and is comparable to newborns deliv-
ered by CS (after onset of labour and/or rupture of
the membranes) who were 1 week younger. No
case of HMD was found in our population when
CS was carried out after completion of 39 post-
menstrual weeks of gestation.
Key words: respiratory distress syndrome; term and
near-term newborns; Caesarean section; hyaline mem-
brane disease
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Introduction
Abbreviations
CS: caesarean section
GA: gestational age (in postmenstrual weeks)
HFV: high-frequency ventilation
HMD: hyaline membrane disease
L/S-ratio: lecithin/sphingomyelin-ratio
MV: mechanical ventilation
OI: oxygenation-index
PICU: paediatric intensive care unit
RDS: respiratory distress syndrome
SP-A: surfactant protein A
quent underlying diagnosis of RDS during the first
48 hours are transient tachypnoea of the newborn,
infections, meconium aspiration syndrome, hya-
line membrane disease (HMD) and perinatal
asphyxia [2]. Besides the forementioned clinical
signs, HMD is characterized by stiff, non-compli-
ant lungs and is due to surfactant deficiency [3].
Chest radiography shows diffuse reticulogranular
opacities, air bronchograms and small lung vol-
umes. In fatal cases, hyaline membranes lining the
terminal airways and alveoli are present. The main
factors predisposing to HMD include prematurity,
male sex and maternal diabetes. Since the publica-
tions of Usher in 1964 and 1971 [4, 5], several stud-
ies showed that also caesarean section (CS), espe-
cially when carried out before the beginning of
labour, even in term or near-term babies, is asso-
ciated with an increased risk for respiratory prob-
lems leading to the term of “iatrogenic RDS”
[6–10].
The aim of the present study was to document
the frequency and severity of HMD in babies de-
livered by CS in order to improve obstetric and
perinatal management.
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Patients and methods
Epidemiologic data
The paediatric intensive care unit (PICU) of the Uni-
versity Children’s Hospital of Bern is a third level refer-
ence unit draining a population of approximately 1.3 mil-
lion people [11]. The number of livebirths in the cantons
of Bern, Solothurn, Jura, and the German speaking parts
of Freiburg and Valais is about 13 000/year. Deducting the
approximately 1000 inborns per year at the University
Women’s Hospital, drained by the Division of Neonatol-
ogy, the catchment area of the PICU covers around 12 000
livebirths/year. All newborn patients admitted are outborn
and transported by ambulance or helicopter by a spe-
cialised neonatal transport team. During the period under
review, (January 1st, 1988 to December 31st, 2000) 2740
newborn babies were admitted, 1569 were on MV (not in-
cluding nasal continuous positive airway pressure), and
334 died (mortality rate 12%). 
Inclusion criteria
To focus on patients at or near term with immaturity
of their surfactant system, the diagnostic criteria of HMD
had to be fulfilled [3], and the birth weight had to be ≥2500
g. Patients with RDS caused by infection, meconium as-
piration or perinatal asphyxia were not included, nor were
patients with congenital malformations affecting respira-
tion. Only patients with severe respiratory distress requir-
ing MV in the form of continuous positive pressure ven-
tilation or high-frequency ventilation (HFV) through an
endotracheal tube were included. Reasons for intubation
were the need of FiO2 >0.6 for sufficient oxygenation, ap-
noea or severe clinical signs of respiratory distress, espe-
cially when facing a neonatal transport. CS either elective
or on an emergency basis had to be the mode of delivery.
The search for these patients was facilitated by a large
computerized database, where the search criteria of
HMD, birth weight ≥2500 g and MV were entered. The
criterion of gestational age was introduced into the elec-
tronic database only in 1995, whereas the birth weight and
the criteria for diagnosis and treatment parameters have
remained unchanged over the whole observation period.
All patient datasheets for the 13 years under consideration
have been filled out by the same three attending paediatric
intensivists (WBP, BD, PJ).
Clinical data
Further data were collected by reviewing individual
clinical charts and chest radiographs. The radiological
signs of HMD had to be present and confirmed by a pae-
diatric radiologist. Postmenstrual age was calculated by
the term given by the caring obstetrician derived from the
first day of last menstruation, possibly corrected by early
ultrasound. Further analysis included the indication for
CS, presence of labour, duration of MV (from endotra-
cheal intubation to extubation), modes of MV (conven-
tional or as rescue treatment, HFV), incidence of pul-
monary air leaks (pneumothorax, pulmonary interstitial
emphysema), highest oxygenation index (OI) [12] and
lowest arterial/alveolar PO2 ratio [13], use of exogenous
surfactant, presence of cardiovascular dysfunction treated
by volume expansion and use of catecholamines, duration
of stay in PICU, abnormal findings in cranial ultrasound
and outcome when leaving PICU (dead or alive). Data
about antenatal steroids were unreliable, and therefore
this item was not analysed.
Patients were then grouped into 2 categories: group
1: elective CS before onset of labour and without rupture
of membranes; and group 2: CS after beginning of labour
or rupture of membranes either on an elective (for history
of caesarean delivery or for abnormal presentation) or
emergency basis (life threatening event for mother and/
or baby).
Statistics
Statistical analysis was done using the Mann-Whit-
ney-rank sum test and Fisher’s exact test. P-values <0.05
were considered to be significant.
Results
During the 13 years under review, 56 new-
borns met the inclusion criteria. Their distribution
over the study period is presented in Figure 1.
Fifty-five patients were intubated before the age of
60 hours, whereas for one patient MV started only
during the fourth day of life. In 34 cases CS was
carried out as a planned caesarean delivery before
onset of labour (group 1). Reasons for CS were one
or more of the following: foregoing CS in 24 cases,
abnormal foetal presentation or small pelvis in 8,
maternal indications in 7, (e.g. hypertension, dia-
betes mellitus, acute pain, foregoing maternal in-
tracranial haemorrhage, maternal viral infection,
uterus myomatosus) and/or twin pregnancy in 1
case. The indications for CS in group 2, which
comprised 22 patients, were as follows: in 13 in-
stances CS was done as an emergency delivery be-
cause of a life-threatening maternal and/or foetal
situation, and in another 8 cases either planned CS
was realized earlier because of the onset of labour
(6 cases) or in response to rupture of the mem-
branes (2 cases). In one case there was a change of
planned vaginal delivery to CS for nonprogression
of delivery. In regards to maternal risk factors like
insulin dependant diabetes mellitus (1 case in each
group), gestational diabetes (1 case in each group)
and thyroid disease (1 case of hyperthyreosis in
group 1) the two groups were comparable.
The main clinical data of the 2 groups are
shown in Table 1. The only statistically significant
difference of the two groups was gestational age
and birth weight. Nine of the patients in group 1
(26%) and 2 patients in group 2 (9%) had a birth
weight >90th percentile, but the difference didn’t
reach statistical significance. None of the patients
was small for GA. The overall mean duration of
MV was 4.2 days; mean of highest OI was 22.9, and
the mean of nadir of arterial/alveolar PO2 ratio was
0.15. Seven (13%) of the newborns had an OI >40.
Fifteen (27%) of the patients were treated with
surfactant, 12 (21%) suffered from pulmonary air
leak, and 19 (34%) needed treatment with cate-
cholamines. One patient in group 1 died. (In this
case, severe respiratory problems needing HFV
were complicated by recurrent pneumothoraces.
On day 5, severe sepsis with multiresistent Achro-
mobacter developed, and the patient died on day 7
because of refractory hypoxaemia. Additional to
hyaline membranes findings at autopsy were
thrombus formation in the vena cava superior and
sinus sagittalis superior.) All other patients sur-
vived.
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Group 1: Elective CS before onset of labour and rupture of membranes
Group 2: Emergency CS or planned CS after rupture of membranes or onset of labour
Figure 1
Distribution of the
cases of RDS over
observation period.
Group 1 Group 2 p-value
Elective CS Emergency CS or 
before onset of labour planned CS after rupture of 
and rupture of membranes membranes or onset of labour
n = 34 n = 22
Gender (m/f) 22 / 12 16 / 6 ns
Gestational age* 37 2/7 (36 0/7–38 6/7) 36 2/7 (34 0/7–38 0/7) p <0.001
(postmenstrual weeks)
Birthweight* (g) 3277 (2570–4470) 2874 (2510–3320) p <0.001
Duration of mechanical ventilation* 4.4 (2.0–8.9) 3.9 (1.6–8.9) ns
(days)
High-frequency ventilation (n) 13 6 ns
Surfactant (n) 8 7 ns
Highest oxygenation-index* 22.7 (5.3–91.9) 23.1 (6.5–44.2) ns
Oxygenation index >40 (n) 5 2 ns
Nadir arterial/alveolar-PaO2-ratio* 0.17 (0.03–0.67) 0.13 (0.05–0.24) ns
Pulmonary air leak (n) 8 4 ns
Catecholamines [dopamine, 14 5 ns
dobutamine, adrenaline] (n)
Duration of PICU-hospitalisation* 7.0 (3.8–12.9) 8.2 (3.8–14.8) ns
(days)
Unilateral subependymal haemorrhage (n) 3 1 ns
Survived to discharge from PICU (n) 33 22 ns
* Data are shown as mean and range (in brackets)
Table 1
Main clinical data.
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Discussion
Main findings
HMD in term/near-term babies after elective
CS without medical reasons still exists despite
warnings in a variety of publications over the last
decades [6–10; 14–16]. In our catchment area of
about 1.3 million inhabitants with approximately
12 000 livebirths/year, 34 babies (group 1) devel-
oped HMD and needed mechanical ventilation
following an elective CS prior to onset of labour.
The HMD incidence of 0.22:1000 livebirths is
slightly higher than an incidence of 0.10‰ re-
cently described in an English population, but in
the latter study there was a restriction to babies ≥37
weeks of gestation [7]. Respiratory distress of these
neonates may be severe with need for respiratory
support by MV for several days. The suffering ba-
bies are at high risk of developing further compli-
cations like pulmonary airleak and cardiovascular
instability, even fatal outcome cannot be excluded,
as shown in our series. Morrison et al. reported an
incidence for RDS with at least oxygen require-
ment after CS of 0.83% for term babies (≥37 weeks
of gestation), which rises to 1.3% when carried out
before onset of labour with an odds ratio of 6.8
compared to the risk of RDS after vaginal delivery
at term [8]. These authors could demonstrate an
increasing incidence of RDS with decreasing GA
from 41 to 37 weeks, with a special increase of risk
when carried out before completion of 39 weeks of
gestation. These results have been confirmed by an
Australian study, elaborating gestational age of
37–38 weeks as well as CS before labour as princi-
ple risk factors in term infants for RDS needing
MV [16]. There was no patient with GA ≥39 0/7
weeks in our population, a fact that has also been
found in earlier reported series [7, 9, 15].
Pathophysiology
Iatrogenic RDS is the result of the coincidence
of three major components: [1] early delivery, [2]
CS as mode of delivery and [3] birth prior to the
onset of labour. What is the evidence that HMD,
which was the clinical, radiological and in 1 case
also the histological diagnosis of our patients,
might be responsible at least partly for the severe
forms of iatrogenic RDS? 
1) As discussed above, a decrease in the inci-
dence of respiratory distress from 36 to 40 weeks
of gestation is well established [7, 8]. During this
period of late gestation the surfactant system
undergoes an important maturation in terms of
increased production and secretion and of changed
composition. With increasing ratio of lecithin to
sphingomyelin concentration (L/S-ratio) in amni-
otic fluid, which has long been used as a marker of
lung maturation, the risk for developing RDS 
decreases [17]. Furthermore, the concentration of
surfactant protein A (SP-A), another component
of pulmonary surfactant, rises in amniotic fluid and
cord blood during late gestation [18]. These same
authors were able to show that a lower level of 
SP-A in cord blood goes along with a higher risk
for developing HMD [19].
Endogenous glucocorticoids are an important
stimulus for foetal lung maturation. Amniotic fluid
concentrations of corticosteroid conjugates, which
are primarily derived from the foetus, increase ap-
proximately five-fold during the third trimester in
parallel with the L/S-ratio [20]. It is suggested that
this rise in endogenous corticoids is one important
factor in lung maturation, especially for surfactant
production in late gestation. 
2) The fact of being delivered by CS enhances
the risk for developing respiratory distress [8, 9, 15,
16, 21]. During vaginal delivery, about one third of
foetal lung fluid is removed by squeezing the baby’s
chest. This removal is missing during delivery by
CS and may be one more explanation as to why 
babies born by CS have a larger residual volume of
lung fluid, secrete less surfactant to the alveolar
surface and are therefore at higher risk to develop
HMD [22].
3) The absence of labour has been shown to be
a risk factor for RDS by many authors [8, 9, 15, 16,
21]. Labour is beneficial for maturation of the sur-
factant system. Babies born by CS before onset of
labour had significantly lower L/S-ratios than
babies born after the beginning of labour, either
vaginally or by CS [23, 24]. Furthermore, SP-A
concentration in cord blood is significantly lower
in babies close to term delivered by elective CS
than in those delivered after onset of labour [18].
However, not only maturation but also secretion
of surfactant is enhanced by labour and triggered
by b-adrenergic agents and prostaglandins
[25–27]. 
As outlined above, the focus of the present
study was on patients with iatrogenic RDS diag-
nosed as HMD. However, the pathophysiological
concept of HMD has undergone some changes. In
recent years, more evidence arose that beside im-
maturity/insufficiency of the surfactant itself, an
insufficient clearance of lung fluid may play an im-
portant role in the pathogenetic mechanisms of
HMD [28]. In very premature infants Na+-ab-
sorption across nasal epithelium is impaired in pa-
tients with HMD [29]. Furthermore, the discussed
risk factors [1]: lower GA, [2] CS and [3] delivery
before labour have also been shown to be impor-
tant in the removal of lung liquid [30–32].
Severity of RDS
As shown in Table 1, patients in both groups
were severely ill. This is documented mainly by
high OI and important use of rescue HFV and cat-
echolamines. Seven newborns even fulfilled crite-
ria for extracorporeal membrane oxygenation
(ECMO) as requested by the UK Collaborative
ECMO Trial Group [33]. However, by the use of
a high-volume strategy during HFV, all our pa-
tients showed a rapid and sustained response in
oxygenation [34]. In some very sick patients addi-
tional pulmonary oedema was initially associated
in the course of RDS. Permeability pulmonary
oedema has been documented in newborns with
HMD [35].
Reserves
The present study was done retrospectively
over a rather long period, during which some ther-
apeutic modalities have changed (introduction of
exogenous surfactant, change from high-fre-
quency jet ventilation to high-frequency oscilla-
tion, and introduction of patient triggered ventila-
tion with tidal volume limitation).
Moreover, some changes within the catchment
area over the years might have occurred. There is
no central register for epidemiological data in this
area, so the overall CS rate is not available. How-
ever, with 12 000 livebirths/year and an annual
mean of 2.6 term babies with HMD after elective
CS in the catchment area of the PICU in Berne (34
patients in group 1 over 13 years), a Swiss nation-
wide number of 15–20 cases/year can be estimated,
which is too high for a principally preventable dis-
ease. Furthermore, there might be additional cases
of severe iatrogenic RDS which do not fulfill the
criteria of HMD but do fulfill the criteria of tran-
sitory tachypnoea of the newborn.
Conclusions
As shown by our series, iatrogenic RDS caused
by too early elective CS before onset of labour is
still a reality. Some of these patients are extremely
ill and need invasive high-tech medical measures
to save their lives. Even then, a fatal outcome
cannot be excluded. Overall, iatrogenic RDS is a
rare cause of RDS in neonates, but as a potentially
preventable disease all possible efforts have to be
undertaken to avoid it. As documented by our
series and recent works by other authors, no case
of severe HMD has been observed after comple-
tion of 39 weeks of GA. 
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